Form 4: West Pharmaceutical Services CFO Reports Stock Transaction
Insider Transaction (Form 4)
Robert W. Mcmahon, SVP & Chief Financial Officer of West Pharmaceutical Services Inc, reported multiple transactions in common stock on August 11, 2026.
Summary
- Option exercise/conversion: acquired 794 Common Stock on August 11, 2026; holds 3,775 after (Direct).
- Tax/exercise-price withholding: disposed of 346 Common Stock at $351.37 ($121,404) on August 11, 2026; holds 3,429 after (Direct).
- Option exercise/conversion: acquired 6,355 Common Stock on August 11, 2026; holds 9,784 after (Direct).
- Tax/exercise-price withholding: disposed of 2,764 Common Stock at $351.37 ($971,072) on August 11, 2026; holds 7,021 after (Direct).
- Option exercise/conversion: disposed of 6,355 Rst. Stock Unit on August 11, 2026; holds 2,119 after (Direct).
- Option exercise/conversion: disposed of 794 Rst. Stock Unit on August 11, 2026; holds 2,383 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Robert W. Mcmahon — Officer (SVP & Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-11 | Option exercise/conversion | Common Stock | 794.469 | — | — | 3,774.96 |
| 2026-08-11 | Tax/exercise-price withholding | Common Stock | 345.515 | $351 | $121.4K | 3,429.445 |
| 2026-08-11 | Option exercise/conversion | Common Stock | 6,354.736 | — | — | 9,784.181 |
| 2026-08-11 | Tax/exercise-price withholding | Common Stock | 2,763.675 | $351 | $971.1K | 7,020.506 |
| 2026-08-11 | Option exercise/conversion | Rst. Stock Unit | 6,354.736 | — | — | 2,118.579 |
| 2026-08-11 | Option exercise/conversion | Rst. Stock Unit | 794.469 | — | — | 2,383.4 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-11 | Option exercise/conversion (794 shares) |
| 2026-08-11 | Tax/exercise-price withholding (346 shares) |
| 2026-08-11 | Option exercise/conversion (6,355 shares) |
| 2026-08-11 | Tax/exercise-price withholding (2,764 shares) |
| 2026-08-11 | Option exercise/conversion (6,355 shares) |
| 2026-08-11 | Option exercise/conversion (794 shares) |
Keywords
insider transaction, Form 4, WST, WEST PHARMACEUTICAL SERVICES INC, neutral, Robert W. Mcmahon
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.